Harpoon Therapeutics SG&A Expense (Quarterly) Trends

Harpoon Therapeutics Inc (DELISTED) (HARP:DL)

23.01 0.00 (0.00%) USD | NASDAQ | Mar 11, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
September 30, 2023	4.262M
June 30, 2023	3.803M
March 31, 2023	4.185M
December 31, 2022	3.854M
September 30, 2022	4.529M
June 30, 2022	5.063M
March 31, 2022	5.401M
December 31, 2021	5.202M
September 30, 2021	4.186M
June 30, 2021	4.335M
March 31, 2021	4.604M
December 31, 2020	3.924M

Date	Value
September 30, 2020	4.428M
June 30, 2020	3.945M
March 31, 2020	3.913M
December 31, 2019	4.332M
September 30, 2019	8.493M
June 30, 2019	3.734M
March 31, 2019	5.832M
December 31, 2018	2.215M
September 30, 2018	1.942M
June 30, 2018	0.967M
March 31, 2018	0.982M
December 31, 2017	0.912M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

3.734M

Minimum

Jun 2019

8.493M

Maximum

Sep 2019

4.566M

Average

4.297M

Median

SG&A Expense (Quarterly) Benchmarks